TYROSINE KINASE INHIBITOR SUPPRESSES CORONARY ARTERIOSCLEROTIC CHANGES AND VASOSPASTIC RESPONSES INDUCED BY CHRONIC TREATMENT WITH INTERLEUKIN-1-BETA IN PIGS IN-VIVO
A. Ito et al., TYROSINE KINASE INHIBITOR SUPPRESSES CORONARY ARTERIOSCLEROTIC CHANGES AND VASOSPASTIC RESPONSES INDUCED BY CHRONIC TREATMENT WITH INTERLEUKIN-1-BETA IN PIGS IN-VIVO, The Journal of clinical investigation, 96(3), 1995, pp. 1288-1294
We recently demonstrated that chronic treatment with IL-1 beta induces
coronary arteriosclerotic changes and vasospastic responses to antaco
ids in pigs in vivo and that those responses are importantly mediated
by PDGF, The receptors for PDGF and other major growth factors are kno
wn to have tyrosine kinase activity, We therefore investigated the eff
ects of a selective tyrosine kinase inhibitor, ST 638, on those respon
ses induced by IL-1 beta in our swine model, Intimal thickening and co
ronary vasospastic responses to serotonin and histamine were induced a
t the site of the coronary artery where IL-1 beta was chronically and
locally applied, These responses were significantly suppressed in a do
se-dependent manner by cotreatment with ST 638, In addition, ST 494, w
hich is an inactive form of ST 638, did not inhibit those responses, T
he treatment with ST 638 alone did not affect the coronary vasoconstri
cting responses to the autacoids, Immunoblotting using an antibody to
phosphotyrosines confirmed the inhibitory effects of ST 638 on the tyr
osine phosphorylations induced by IL-1 beta, These results thus sugges
t that tyrosine kinase activation may play an important role in mediat
ing the effects of IL-1 beta, while also suggesting that ST 638 has an
inhibitory effect on the arteriosclerotic changes and vasospastic res
ponses to autacoids in our swine model in vivo.